Kindred Companion Sciences

Kindred Companion Sciences is a company headquartered in the United States. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Kindred Companion Sciences develops gene-edited dogs that do not produce the major dog allergen, aiming to enable allergy-sensitive households to live with companion dogs. Their work involves precise genomic editing of canine cells to remove the Can f 1 allergen gene, with peer-reviewed research and adherence to regulatory processes.